LEYNA MIDKIFF: Open Payments
NPI 1831595735 · MERRILLVILLE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,612 in 67 payments from 21 companies in 2025. Trend: 2023 $1,503 · 2024 $1,582 · 2025 $1,612
Food & beverage: $1,527Education: $85
| Company | Payments | Amount |
|---|---|---|
| Sumitomo Pharma America, Inc. | 26 | $417 |
| Janssen Biotech, Inc. | 9 | $254 |
| PROGENICS PHARMACEUTICALS, INC. | 4 | $188 |
| Astellas Pharma US Inc | 7 | $155 |
| Procept Biorobotics Corporation | 1 | $133 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $59 |
| UROGEN PHARMA, INC. | 2 | $52 |
| Olympus America Inc. | 1 | $41 |
| Boston Scientific Corporation | 2 | $41 |
| Endo USA, Inc. | 1 | $32 |
Products named: GEMTESA, ERLEADA, PYLARIFY, Xtandi, ORGOVYX, AQUABEAM ROBOTIC SYSTEM, Nubeqa, JELMYTO.
Industry payments across IN — which companies pay providers there.
